Disclaimer:
Medidex is not a provider of medical services and all information is provided for the convenience of the user. No medical decisions should be made based on the information provided on this website without first consulting a licensed healthcare provider.This website is intended for persons 18 years or older. No person under 18 should consult this website without the permission of a parent or guardian.
EPIPEN
Overview
What is EPIPEN?
EpiPen (epinephrine injection, USP) 0.3 mg and EpiPen Jr (epinephrine injection, USP) 0.15 mg are auto-injectors and combination products containing drug and device components.
Each EpiPen Auto-Injector, 0.3 mg delivers a single dose of 0.3 mg epinephrine from epinephrine injection, USP 0.3 mg/0.3 mL in a sterile solution.
Each EpiPen Jr Auto-Injector, 0.15 mg delivers a single dose of 0.15 mg epinephrine from epinephrine injection, USP 0.15 mg/0.3 mL in a sterile solution.
The EpiPen and EpiPen Jr each contain 2 mL epinephrine solution. Approximately 1.7 mL remains in the auto-injector after activation, but is not available for future use, and should be discarded.
Each 0.3 mL in the EpiPen Auto-Injector contains 0.3 mg epinephrine, 1.8 mg sodium chloride, 0.5 mg sodium metabisulfite, hydrochloric acid to adjust pH, and Water for Injection. The pH range is 2.2–5.0.
Each 0.3 mL in the EpiPen Jr Auto-Injector contains 0.15 mg epinephrine, 1.8 mg sodium chloride, 0.5 mg sodium metabisulfite, hydrochloric acid to adjust pH, and Water for Injection. The pH range is 2.2-5.0.
Epinephrine is a sympathomimetic catecholamine. Chemically, epinephrine is (-)-3,4- Dihydroxy-α-[(methylamino)methyl]benzyl alcohol with the following structure:
Epinephrine solution deteriorates rapidly on exposure to air or light, turning pink from oxidation to adrenochrome and brown from the formation of melanin. Replace EpiPen and EpiPen Jr if the epinephrine solution appears discolored (pinkish or brown color), cloudy, or contains particles.
Thoroughly review the patient instructions and operation of EpiPen or EpiPen Jr with patients and caregivers prior to use [].
What does EPIPEN look like?
What are the available doses of EPIPEN?
What should I talk to my health care provider before I take EPIPEN?
How should I use EPIPEN?
EpiPen and EpiPen Jr are indicated in the emergency treatment of allergic reactions (Type I) including anaphylaxis to stinging insects (e.g., order Hymenoptera, which include bees, wasps, hornets, yellow jackets and fire ants) and biting insects (e.g., triatoma, mosquitoes), allergen immunotherapy, foods, drugs, diagnostic testing substances (e.g., radiocontrast media) and other allergens, as well as idiopathic anaphylaxis or exercise-induced anaphylaxis.
EpiPen and EpiPen Jr are intended for immediate administration in patients who are determined to be at increased risk for anaphylaxis, including individuals with a history of anaphylactic reactions.
Anaphylactic reactions may occur within minutes after exposure and consist of flushing, apprehension, syncope, tachycardia, thready or unobtainable pulse associated with a fall in blood pressure, convulsions, vomiting, diarrhea and abdominal cramps, involuntary voiding, wheezing, dyspnea due to laryngeal spasm, pruritus, rashes, urticaria or angioedema.
EpiPen and EpiPen Jr are intended for immediate administration as emergency supportive therapy only and are not a substitute for immediate medical care.
Selection of the appropriate dosage strength (EpiPen 0.3 mg or EpiPen Jr 0.15 mg) is determined according to patient body weight.
Inject EpiPen or EpiPen Jr intramuscularly or subcutaneously into the anterolateral aspect of the thigh, through clothing if necessary. Instruct caregivers of young children who are prescribed an EpiPen or EpiPen Jr and who may be uncooperative and kick or move during an injection to hold the leg firmly in place and limit movement prior to and during an injection [].
Each EpiPen or EpiPen Jr contains a single dose of epinephrine for single-use injection. Since the doses of epinephrine delivered from EpiPen or EpiPen Jr are fixed, consider using other forms of injectable epinephrine if doses lower than 0.15 mg are deemed necessary.
The prescriber should carefully assess each patient to determine the most appropriate dose of epinephrine, recognizing the life-threatening nature of the reactions for which this drug is indicated. With severe persistent anaphylaxis, repeat injections with an additional EpiPen or EpiPen Jr may be necessary. More than two sequential doses of epinephrine should only be administered under direct medical supervision [].
The epinephrine solution in the clear window of the EpiPen Auto-Injector should be inspected visually for particulate matter and discoloration. Epinephrine is light sensitive and should be stored in the carrier tube provided to protect it from light []
What interacts with EPIPEN?
Sorry No Records found
What are the warnings of EPIPEN?
Sorry No Records found
What are the precautions of EPIPEN?
Sorry No Records found
What are the side effects of EPIPEN?
Sorry No records found
What should I look out for while using EPIPEN?
None
What might happen if I take too much EPIPEN?
Overdosage of epinephrine may produce extremely elevated arterial pressure, which may result in cerebrovascular hemorrhage, particularly in elderly patients. Overdosage may also result in pulmonary edema because of peripheral vascular constriction together with cardiac stimulation. Treatment consists of rapidly acting vasodilators or alpha-adrenergic blocking drugs and/or respiratory support.
Epinephrine overdosage can also cause transient bradycardia followed by tachycardia, and these may be accompanied by potentially fatal cardiac arrhythmias. Premature ventricular contractions may appear within one minute after injection and may be followed by multifocal ventricular tachycardia (prefibrillation rhythm). Subsidence of the ventricular effects may be followed by atrial tachycardia and occasionally by atrioventricular block. Treatment of arrhythmias consists of administration of a beta-adrenergic blocking drug such as propranolol.
Overdosage sometimes results in extreme pallor and coldness of the skin, metabolic acidosis, and kidney failure. Suitable corrective measures must be taken in such situations.
How should I store and handle EPIPEN?
Store at controlled room temperature 20° to 25°C (68° to 77°F) [see USP].Citalopram Tablets, USP, , are light orange, oval, film-coated tablets and debossed “IP 52” on the obverse and plain on the reverse.They are available as follows:Bottles of 30: NDC 65162-052-03Bottles of 100: NDC 65162-052-10Bottles of 500: NDC 65162-052-50Bottles of 1000: NDC 65162-052-11Citalopram Tablets, USP, , are pink, oval, bisected, film-coated tablets and debossed “IP” bisect “53” on the obverse and plain on the reverse.They are available as follows:Bottles of 30: NDC 65162-053-03Bottles of 100: NDC 65162-053-10Bottles of 500: NDC 65162-053-50Bottles of 1000: NDC 65162-053-11Citalopram Tablets, USP, , are white, oval, bisected, film-coated tablets and debossed “IP” bisect “54” on the obverse and plain on the reverse.They are available as follows:Bottles of 30: NDC 65162-054-03Bottles of 100: NDC 65162-054-10Bottles of 500: NDC 65162-054-50Bottles of 1000: NDC 65162-054-11Store at 20° to 25°C (68° to 77°F); excursions permitted between 15° to 30°C (59° to 86°F) [see USP Controlled Room Temperature]. Citalopram Tablets, USP, , are light orange, oval, film-coated tablets and debossed “IP 52” on the obverse and plain on the reverse.They are available as follows:Bottles of 30: NDC 65162-052-03Bottles of 100: NDC 65162-052-10Bottles of 500: NDC 65162-052-50Bottles of 1000: NDC 65162-052-11Citalopram Tablets, USP, , are pink, oval, bisected, film-coated tablets and debossed “IP” bisect “53” on the obverse and plain on the reverse.They are available as follows:Bottles of 30: NDC 65162-053-03Bottles of 100: NDC 65162-053-10Bottles of 500: NDC 65162-053-50Bottles of 1000: NDC 65162-053-11Citalopram Tablets, USP, , are white, oval, bisected, film-coated tablets and debossed “IP” bisect “54” on the obverse and plain on the reverse.They are available as follows:Bottles of 30: NDC 65162-054-03Bottles of 100: NDC 65162-054-10Bottles of 500: NDC 65162-054-50Bottles of 1000: NDC 65162-054-11Store at 20° to 25°C (68° to 77°F); excursions permitted between 15° to 30°C (59° to 86°F) [see USP Controlled Room Temperature]. Citalopram Tablets, USP, , are light orange, oval, film-coated tablets and debossed “IP 52” on the obverse and plain on the reverse.They are available as follows:Bottles of 30: NDC 65162-052-03Bottles of 100: NDC 65162-052-10Bottles of 500: NDC 65162-052-50Bottles of 1000: NDC 65162-052-11Citalopram Tablets, USP, , are pink, oval, bisected, film-coated tablets and debossed “IP” bisect “53” on the obverse and plain on the reverse.They are available as follows:Bottles of 30: NDC 65162-053-03Bottles of 100: NDC 65162-053-10Bottles of 500: NDC 65162-053-50Bottles of 1000: NDC 65162-053-11Citalopram Tablets, USP, , are white, oval, bisected, film-coated tablets and debossed “IP” bisect “54” on the obverse and plain on the reverse.They are available as follows:Bottles of 30: NDC 65162-054-03Bottles of 100: NDC 65162-054-10Bottles of 500: NDC 65162-054-50Bottles of 1000: NDC 65162-054-11Store at 20° to 25°C (68° to 77°F); excursions permitted between 15° to 30°C (59° to 86°F) [see USP Controlled Room Temperature]. Citalopram Tablets, USP, , are light orange, oval, film-coated tablets and debossed “IP 52” on the obverse and plain on the reverse.They are available as follows:Bottles of 30: NDC 65162-052-03Bottles of 100: NDC 65162-052-10Bottles of 500: NDC 65162-052-50Bottles of 1000: NDC 65162-052-11Citalopram Tablets, USP, , are pink, oval, bisected, film-coated tablets and debossed “IP” bisect “53” on the obverse and plain on the reverse.They are available as follows:Bottles of 30: NDC 65162-053-03Bottles of 100: NDC 65162-053-10Bottles of 500: NDC 65162-053-50Bottles of 1000: NDC 65162-053-11Citalopram Tablets, USP, , are white, oval, bisected, film-coated tablets and debossed “IP” bisect “54” on the obverse and plain on the reverse.They are available as follows:Bottles of 30: NDC 65162-054-03Bottles of 100: NDC 65162-054-10Bottles of 500: NDC 65162-054-50Bottles of 1000: NDC 65162-054-11Store at 20° to 25°C (68° to 77°F); excursions permitted between 15° to 30°C (59° to 86°F) [see USP Controlled Room Temperature]. Citalopram Tablets, USP, , are light orange, oval, film-coated tablets and debossed “IP 52” on the obverse and plain on the reverse.They are available as follows:Bottles of 30: NDC 65162-052-03Bottles of 100: NDC 65162-052-10Bottles of 500: NDC 65162-052-50Bottles of 1000: NDC 65162-052-11Citalopram Tablets, USP, , are pink, oval, bisected, film-coated tablets and debossed “IP” bisect “53” on the obverse and plain on the reverse.They are available as follows:Bottles of 30: NDC 65162-053-03Bottles of 100: NDC 65162-053-10Bottles of 500: NDC 65162-053-50Bottles of 1000: NDC 65162-053-11Citalopram Tablets, USP, , are white, oval, bisected, film-coated tablets and debossed “IP” bisect “54” on the obverse and plain on the reverse.They are available as follows:Bottles of 30: NDC 65162-054-03Bottles of 100: NDC 65162-054-10Bottles of 500: NDC 65162-054-50Bottles of 1000: NDC 65162-054-11Store at 20° to 25°C (68° to 77°F); excursions permitted between 15° to 30°C (59° to 86°F) [see USP Controlled Room Temperature]. Citalopram Tablets, USP, , are light orange, oval, film-coated tablets and debossed “IP 52” on the obverse and plain on the reverse.They are available as follows:Bottles of 30: NDC 65162-052-03Bottles of 100: NDC 65162-052-10Bottles of 500: NDC 65162-052-50Bottles of 1000: NDC 65162-052-11Citalopram Tablets, USP, , are pink, oval, bisected, film-coated tablets and debossed “IP” bisect “53” on the obverse and plain on the reverse.They are available as follows:Bottles of 30: NDC 65162-053-03Bottles of 100: NDC 65162-053-10Bottles of 500: NDC 65162-053-50Bottles of 1000: NDC 65162-053-11Citalopram Tablets, USP, , are white, oval, bisected, film-coated tablets and debossed “IP” bisect “54” on the obverse and plain on the reverse.They are available as follows:Bottles of 30: NDC 65162-054-03Bottles of 100: NDC 65162-054-10Bottles of 500: NDC 65162-054-50Bottles of 1000: NDC 65162-054-11Store at 20° to 25°C (68° to 77°F); excursions permitted between 15° to 30°C (59° to 86°F) [see USP Controlled Room Temperature]. Citalopram Tablets, USP, , are light orange, oval, film-coated tablets and debossed “IP 52” on the obverse and plain on the reverse.They are available as follows:Bottles of 30: NDC 65162-052-03Bottles of 100: NDC 65162-052-10Bottles of 500: NDC 65162-052-50Bottles of 1000: NDC 65162-052-11Citalopram Tablets, USP, , are pink, oval, bisected, film-coated tablets and debossed “IP” bisect “53” on the obverse and plain on the reverse.They are available as follows:Bottles of 30: NDC 65162-053-03Bottles of 100: NDC 65162-053-10Bottles of 500: NDC 65162-053-50Bottles of 1000: NDC 65162-053-11Citalopram Tablets, USP, , are white, oval, bisected, film-coated tablets and debossed “IP” bisect “54” on the obverse and plain on the reverse.They are available as follows:Bottles of 30: NDC 65162-054-03Bottles of 100: NDC 65162-054-10Bottles of 500: NDC 65162-054-50Bottles of 1000: NDC 65162-054-11Store at 20° to 25°C (68° to 77°F); excursions permitted between 15° to 30°C (59° to 86°F) [see USP Controlled Room Temperature].
Clinical Information
Chemical Structure
No Image foundClinical Pharmacology
Epinephrine acts on both alpha- and beta-adrenergic receptors.
Non-Clinical Toxicology
NoneTetracycline, a bacteriostatic antibiotic, may antagonize the bactericidal effect of penicillin and concurrent use of these drugs should be avoided.
EpiPen and EpiPen Jr are intended for immediate administration as emergency supportive therapy and are not intended as a substitute for immediate medical care. More than two sequential doses of epinephrine should only be administered under direct medical supervision [].
Due to the lack of randomized, controlled clinical trials of epinephrine for the treatment of anaphylaxis, the true incidence of adverse reactions associated with the systemic use of epinephrine is difficult to determine. Adverse reactions reported in observational trials, case reports, and studies are listed below.
Common adverse reactions to systemically administered epinephrine include anxiety; apprehensiveness; restlessness; tremor; weakness; dizziness; sweating; palpitations; pallor; nausea and vomiting; headache; and/or respiratory difficulties. These symptoms occur in some persons receiving therapeutic doses of epinephrine, but are more likely to occur in patients with hypertension or hyperthyroidism [ ].
Arrhythmias, including fatal ventricular fibrillation, have been reported, particularly in patients with underlying cardiac disease or those receiving certain drugs [ ].
Rapid rises in blood pressure have produced cerebral hemorrhage, particularly in elderly patients with cardiovascular disease [ ].
Angina may occur in patients with coronary artery disease [ ].
Rare cases of stress cardiomyopathy have been reported in patients treated with epinephrine.
Accidental injection into the digits, hands or feet may result in loss of blood flow to the affected area [].
Adverse events experienced as a result of accidental injections may include increased heart rate, local reactions including injection site pallor, coldness and hypoesthesia or injury at the injection site resulting in bruising, bleeding, discoloration, erythema or skeletal injury.
Lacerations, bent needles, and embedded needles have been reported when EpiPen has been injected into the thigh of young children who are uncooperative and kick or move during the injection [].
Injection into the buttock has resulted in cases of gas gangrene [ ]
Rare cases of serious skin and soft tissue infections, including necrotizing fasciitis and myonecrosis caused by Clostridia (gas gangrene), have been reported following epinephrine injection, including EpiPen, in the thigh [].
Reference
This information is obtained from the National Institute of Health's Standard Packaging Label drug database.
"https://dailymed.nlm.nih.gov/dailymed/"
While we update our database periodically, we cannot guarantee it is always updated to the latest version.
Review
Read user comments about the side effects, benefits, and effectiveness of losartan oral.
Overall User Ratings
514Total User Reviews
User Reviews
Learn about
User Reviews
Professional
Clonazepam Description Each single-scored tablet, for oral administration, contains 0.5 mg, 1 mg, or 2 mg Clonazepam, USP, a benzodiazepine. Each tablet also contains corn starch, lactose monohydrate, magnesium stearate, microcrystalline cellulose, and povidone. Clonazepam tablets USP 0.5 mg contain Yellow D&C No. 10 Aluminum Lake. Clonazepam tablets USP 1 mg contain Yellow D&C No. 10 Aluminum Lake, as well as FD&C Blue No. 1 Aluminum Lake. Chemically, Clonazepam, USP is 5-(o-chlorophenyl)-1,3-dihydro-7-nitro-2H-1,4-benzodiazepin-2-one. It is a light yellow crystalline powder. It has the following structural formula: C15H10ClN3O3 M.W. 315.72Tips
Tips
Interactions
Interactions
A total of 440 drugs (1549 brand and generic names) are known to interact with Imbruvica (ibrutinib). 228 major drug interactions (854 brand and generic names) 210 moderate drug interactions (691 brand and generic names) 2 minor drug interactions (4 brand and generic names) Show all medications in the database that may interact with Imbruvica (ibrutinib).